ReviewBiomedicines2023

The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review.

Aikaterini Tsiogka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.